Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2

21 Oct 2024

Abstract excerpt

BACKGROUND: Cancer patients are more susceptible to an aggressive course of COVID-19. Developing biomarkers identifying cancer patients at high risk of COVID-19-related death could help determine who needs early clinical intervention. The miRNAs hosted in the genomic regions associated with the risk of aggressive COVID-19 could represent potential biomarkers for clinical outcomes. PATIENTS AND METHODS: Plasma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Long-Term Effects of COVID-19
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39434078
DOI: 10.1186/s12943-024-02094-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2PMID 39434078Read ↗

MicroRNAs immune response profile to COVID-19 vaccine boost in cancer patients under active treatmentSemantic proximity Read ↗

COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.Semantic proximity Read ↗

Upregulation of distinct miRNAs in SARS-CoV-2 infected individuals: A differential signature of circulating miRNAsSemantic proximity Read ↗

Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and TherapySemantic proximity Read ↗

Incidence and Immunomic Features of Apyretic COVID-19 in Patients Affected by Solid Tumors: a Prospective Cohort Study.Semantic proximity Read ↗

Role of microRNAs in COVID-19 with implications for therapeuticsSemantic proximity Read ↗

Covid-19 And Cancer: Insights Into Their Association And Influence On Genetic And Epigenetic LandscapeSemantic proximity Read ↗

The Role of miRNAs in COVID-19 DiseaseSemantic proximity Read ↗

Cancer inpatient with COVID-19: a report from the Brazilian National Cancer InstituteSemantic proximity Read ↗

Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patientsSemantic proximity Read ↗

Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approachSemantic proximity Read ↗

Assessing COVID-19 Infection, and Severe Disease Risk in Cancer Patients and Survivors: The Role of Vaccination Status, Circulating Variants, and Comorbidities—A Population-Based Study in Northern ItalySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.